Abliva Management
Management criteria checks 2/4
Abliva's CEO is Ellen Donnelly, appointed in Feb 2021, has a tenure of 3.75 years. total yearly compensation is SEK7.03M, comprised of 54.1% salary and 45.9% bonuses, including company stock and options. directly owns 0.023% of the company’s shares, worth SEK50.57K. The average tenure of the management team and the board of directors is 8.8 years and 7.8 years respectively.
Key information
Ellen Donnelly
Chief executive officer
SEK 7.0m
Total compensation
| CEO salary percentage | 54.1% |
| CEO tenure | 3.8yrs |
| CEO ownership | 0.02% |
| Management average tenure | 8.8yrs |
| Board average tenure | 7.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -SEK 102m |
| Mar 31 2024 | n/a | n/a | -SEK 98m |
| Dec 31 2023 | SEK 7m | SEK 4m | -SEK 96m |
| Sep 30 2023 | n/a | n/a | -SEK 88m |
| Jun 30 2023 | n/a | n/a | -SEK 80m |
| Mar 31 2023 | n/a | n/a | -SEK 79m |
| Dec 31 2022 | SEK 6m | SEK 3m | -SEK 85m |
| Sep 30 2022 | n/a | n/a | -SEK 105m |
| Jun 30 2022 | n/a | n/a | -SEK 114m |
| Mar 31 2022 | n/a | n/a | -SEK 124m |
| Dec 31 2021 | SEK 4m | SEK 2m | -SEK 123m |
Compensation vs Market: Ellen's total compensation ($USD634.16K) is above average for companies of similar size in the UK market ($USD356.31K).
Compensation vs Earnings: Ellen's compensation has increased whilst the company is unprofitable.
CEO
Ellen Donnelly (50 yo)
3.8yrs
Tenure
SEK 7,029,000
Compensation
Dr. Ellen K. Donnelly, Ph D has been Chief Executive Officer at Abliva AB (publ) since February 03, 2021. She serves as Independent Director at Modus Therapeutics Holding Ab since 2020.Dr. Donnelly had be...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 3.8yrs | SEK 7.03m | 0.023% SEK 50.6k | |
| Deputy CEO | 10.9yrs | no data | 0.020% SEK 42.5k | |
| Chief Scientific Officer & VP of Discovery | 24.8yrs | SEK 247.00k | 0.046% SEK 99.2k | |
| Communications Officer & Lab Manager | no data | no data | no data | |
| Chief Medical Officer and VP of Preclinical & Clinical Development | 8.8yrs | no data | 0.053% SEK 115.0k | |
| Vice President of Clinical Operations | 1.8yrs | no data | 0.0013% SEK 2.9k | |
| Consultant | no data | no data | no data |
8.8yrs
Average Tenure
52yo
Average Age
Experienced Management: 0QDU's management team is seasoned and experienced (8.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of the Board | 8.6yrs | SEK 1.43m | 0.14% SEK 309.9k | |
| Independent Director | 7.8yrs | SEK 477.00k | 0.0085% SEK 18.4k | |
| Independent Director | 7.8yrs | SEK 438.00k | 0.0039% SEK 8.4k | |
| Independent Director | 6.6yrs | SEK 464.00k | no data | |
| Independent Director | 4.3yrs | no data | 14.71% SEK 32.0m |
7.8yrs
Average Tenure
64yo
Average Age
Experienced Board: 0QDU's board of directors are considered experienced (7.8 years average tenure).